dioscin has been researched along with Breast Cancer in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Ajouaoi, S; Ben Mrid, R; Bouargalne, Y; Bouchmaa, N; Cacciola, F; El Fatimy, R; Nhiri, M; Zyad, A | 1 |
Cai, FY; Fu, M; He, SY; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Liu, XZ; Niu, FJ; Yao, XM; Zhang, L | 1 |
Jang, JH; Kim, EA; Kim, JY; Kim, S; Lee, TJ; Lee, YH; Sohn, HY; Song, IH; Sung, EG | 1 |
Ali, Z; Aumsuwan, P; Avula, B; Dasmahapatra, AK; Helferich, WG; Katzenellenbogen, BS; Khan, IA; Khan, SI; Shariat-Madar, Z; Walker, LA | 1 |
Huo, X; Liu, K; Liu, Q; Liu, Z; Meng, Q; Peng, J; Sun, H; Sun, P; Wang, C; Wang, L | 1 |
5 other study(ies) available for dioscin and Breast Cancer
Article | Year |
---|---|
In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer.
Topics: Antineoplastic Agents; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum; Female; Humans; Hydrogen Peroxide; Leukocytes, Mononuclear; Triple Negative Breast Neoplasms | 2023 |
GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial-mesenchymal transition.
Topics: Breast Neoplasms; Cell Line, Tumor; Daunorubicin; Diosgenin; Epithelial-Mesenchymal Transition; Humans; Liposomes | 2020 |
Dioscin induces caspase-independent apoptosis through activation of apoptosis-inducing factor in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Breast Neoplasms; Caspases; Cell Line, Tumor; Diosgenin; Female; Humans; Inhibitor of Apoptosis Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2 | 2014 |
The anticancer potential of steroidal saponin, dioscin, isolated from wild yam (Dioscorea villosa) root extract in invasive human breast cancer cell line MDA-MB-231 in vitro.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dioscorea; Diosgenin; Dose-Response Relationship, Drug; Humans; MCF-7 Cells; Neoplasm Invasiveness; Phytosterols; Plant Extracts; Plant Roots; Saponins; Treatment Outcome | 2016 |
Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1.
Topics: ATP Binding Cassette Transporter, Subfamily B; Autophagy; Breast Neoplasms; Cell Proliferation; Diosgenin; Down-Regulation; Doxorubicin; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; NF-kappa B; Promoter Regions, Genetic; Signal Transduction | 2016 |